HC9 Ventures is a New York-based specialist healthtech investor that backs Seed and Series A companies, with an $83M latest fund.
3 people on the investing team, 2 of them partners who can make the call. Partners are listed first.
Work here and something is wrong? Ask for a correction.


Raising a pre-seed or seed round? We write $1M to $5M first checks and help founders with distribution. A partner reads every deck.
Send your deckOne email when this firm shows new activity. Nothing else.
HC9 Ventures reports entry at seed, series a.
HC9 Ventures has not reported a check size.
HC9 Ventures has not reported a lead preference.
Charlie Falcone (Co-Founder & General Partner), Richard Lungen (Co-Founder & General Partner).
No recent activity since September 2026.
Work at HC9 Ventures? Claim or correct this profile.